BUSINESS● LOW2h ago · Oct 30, 2026, 10:32 AM
Regeneron Pharmaceuticals Non-GAAP EPS of $20.07 beats by $3.82, revenue of $5.1B beats by $540M
Seeking Alpha Tech · north america
Regeneron Pharmaceuticals reported non-GAAP earnings per share and revenue that significantly exceeded analyst expectations. This indicates a strong financial performance for the pharmaceutical company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS9m agoBGFI on the Stock Exchange: after a difficult start, the recipe for a record oversubscriptionJeune AfriqueBUSINESS31m agoEmployment Cost Index growth decelerates in Q3, as expectedSeeking Alpha Tech